Literature DB >> 16798251

Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.

Subroto Paul1, Francisco M Marty, Yolonda L Colson.   

Abstract

We describe a 57-year-old woman with acute lymphoblastic leukemia who had a cavitary lesion develop in the right upper lobe caused by Cunninghamella bertholletiae, a zygomycete. The infection was resistant to both high-dose liposomal amphotericin B and voriconazole. The current report demonstrates successful treatment, even in the setting of subsequent bone marrow transplantation and immunosuppression, using a combination of surgical resection and posaconazole therapy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16798251     DOI： 10.1016/j.athoracsur.2005.09.043

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.

Authors:  F Javier Pastor; Mery Ruíz-Cendoya; Isabel Pujol; Emilio Mayayo; Deanna A Sutton; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

Review 3.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

4.  Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Authors:  Hikari Ota; Hisashi Yamamoto; Muneyoshi Kimura; Hideki Araoka; Takeshi Fujii; Takashi Umeyama; Hideaki Ohno; Yoshitsugu Miyazaki; Daisuke Kaji; Yuki Taya; Aya Nishida; Kazuya Ishiwata; Masanori Tsuji; Shinsuke Takagi; Yuki Asano-Mori; Go Yamamoto; Naoyuki Uchida; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Akiko Yoneyama; Shigeyoshi Makino; Shuichi Taniguchi
Journal:  Mycopathologia       Date:  2017-06-02       Impact factor: 2.574

5.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

6.  Acute Cardiac Failure due to Intra-Atrial Mass Caused by Zygomycetes in an Immunocompromised Paediatric Patient.

Authors:  G J van de Glind; C E M Gidding; C M W Verlaat; K Duthoi; A P C Backx; P E Verweij; A Warris
Journal:  Case Rep Med       Date:  2010-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.